IPOs for July 16th
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
IPO for Chinese Wealth Manager Jupai Holdings (JP) Trades Modestly Higher
July 16, 2015 2:13 PM EDTToday's IPO for Chinese wealth management firm Jupai Holdings (NYSE: JP) is trading at $10.76 after pricing 5,300,000 American Depositary Shares (ADSs), each representing six ordinary shares of the Company, at $10.00 per ADS. The ADSs opened earlier on the NYSE at $10.41.
The IPO... More
ProNAi Therapeutics (DNAI) IPO Opens Up 69%
July 16, 2015 11:00 AM EDTToday's IPO for ProNAi Therapeutics, Inc. (Nasdaq: DNAI) opened for trading at $28.68 after pricing of its initial public offering of 8,100,000 shares of its common stock at a price to the public of $17.00 per share
Jefferies LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering. BofA Merrill Lynch is also serving as ProNAi's Strategic IPO Advisor. Wedbush PacGrow and SunTrust Robinson Humphrey are acting as co-managers.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of... More
ProNAi Therapeutics (DNAI) Prices 8.1M Common Stock IPO at $17/Share
July 16, 2015 10:13 AM EDTProNAi Therapeutics, Inc. (Nasdaq: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced the pricing of its initial public offering of 8,100,000 shares of its common stock at a price to the public of... More
Jupai Holdings (JP) Prices 5.3M ADS IPO at $10/ADS, at the Lower-End of Expectations
July 16, 2015 10:12 AM EDTJupai Holdings Limited ("Jupai" or the "Company") (NYSE: JP), a leading third-party wealth management service provider in China, today announced that its initial public offering of 5,300,000 American Depositary Shares ("ADSs"), each representing six ordinary shares of the Company, was priced at $10.00 per... More
